- Paraneoplastic dermatomyositis in hereditary breast and ovarian cancer syndrome.
- Kumar N, Deo S.
- Breast J. 2020 May 18. doi: 10.1111/tbj.13888. Epub ahead of print.
- PMID: 32419320
- PubMed abstract
- Source abstract
- Clovis Oncology's Rubraca Gets FDA Approval for BRCA-Mutated, Difficult-to-Treat Prostate Cancer.
- [No author given]
- Precision Oncology News. 2020 May 15.
- News
- Free Full Text